Martin Quibell

Geen lopende functies

Health Technology

Consumer Services

Profiel

Martin Quibell is the founder and Chief Scientific Officer at Pedanius Therapeutics Ltd. which is founded in 2018.
He previously held positions as Director-Medicinal Chemistry at Acambis Plc, Vice President-Medicinal Chemistry at Amura Holdings Ltd. and Amura Therapeutics Ltd., and Principal at Incenta Ltd. Dr. Quibell earned a doctorate degree from the University of Birmingham in 1991 and an undergraduate degree from the University of Portsmouth.

Eerdere bekende functies van Martin Quibell

Bedrijven	Functie	Einde
Incenta Ltd.	Corporate Officer/Principal	-
Amura Therapeutics Ltd.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Corporate Officer/Principal	-
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Hoofd Techniek/Wetenschap/O&O	-

Ervaring van Martin Quibell in detail bekijken

Opleiding van Martin Quibell

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Martin Quibell in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	6
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Health Technology
University of Birmingham University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Portsmouth University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Health Technology
Amura Therapeutics Ltd.
Incenta Ltd.